<div id="readability-page-1"><p>In a report released yesterday, Anchal Verma from J.P. Morgan reiterated a Buy rating on ConvaTec. The company’s shares closed yesterday at p245.80.</p><h3>Meet Your ETF AI Analyst</h3><ul><li> Discover how TipRanks' <i>ETF</i> AI Analyst  can help you make smarter investment decisions </li><li>   Explore ETFs TipRanks' users love  and see what insights the <b><i>ETF</i> AI Analyst</b> reveals about the ones you follow.</li></ul> <p>Verma covers the Healthcare sector, focusing on stocks such as Carl Zeiss Meditec, DiaSorin S.p.A., and ConvaTec. According to TipRanks, Verma has an average return of <span>13.5%</span> and an 80.65% success rate on recommended stocks. </p> <p>Currently, the analyst consensus on ConvaTec is a Strong Buy with an average price target of p311.33, which is a 26.66% upside from current levels. In a report released yesterday, Barclays also maintained a Buy rating on the stock with a £3.25 price target.</p></div>

CTEC

<p>J.P. Morgan's Anchal Verma reiterated a Buy rating on ConvaTec, with shares closing at p245.80. The analyst consensus is a Strong Buy with a price target of p311.33, indicating a 26.66% upside. Barclays also maintained a Buy rating with a £3.25 target.</p>

ConvaTec (CTEC) Gets a Buy from J.P. Morgan